Podcasts

This month we’ll look at the Biden administration's relaunch of its cancer moonshot initiative, addressing social determinants of health, and more.

In this CAPcast, Moira Larsen, MD, MBA, FCAP, and Karim Sirgi, MD, MBA, FCAP, will discuss how to determine workload distribution while navigating the associated group dynamics.

Trichomoniasis is the most common, non-viral, sexually transmitted infection. Pathologists providing laboratory testing for this infection should understand the advantages and disadvantages of the commercially available, FDA-approved/cleared methods.

A new study just published in the Archives of Pathology & Laboratory Medicine found that pathology abnormalities composing SARS-CoV-2 placentitis cause widespread and severe placental destruction that can result in stillbirths.

This month we'll look at testing supply shortages caused by the Omicron variant, new dispute guidelines in the No Surprises Act, and more.

In this CAPcast, Dr. Rebecca Obeng discusses the range of services and resources that biorepositories can provide researchers as well as the benefits and value of accreditation for biorepositories.

In this CAPcast, Matthew Krasowski, MD, FCAP, Chair of the CAP Toxicology Committee, discusses the laboratory’s role in medical device recall, such as this recent incident, and how both CAP-accredited laboratories and inspectors should respond to recalls.

The CAP is advocating to make the IDR process truly independent and fair to all participants. We spoke with Dr. Theresa Emory, chair of the CAP's Payment Policy Subcommittee, to learn more.

r. Yao has written an article about how using next-generation sequencing techniques allows more accurate initial diagnosis, as well as high sensitivity for detecting minimal residual disease and therefore improving post-treatment outcomes, as she’ll explain in this CAPcast interview.

What are some common challenges that pathologists face when they are transitioning from training to practice? This CAPcast features a panel discussion recorded during the 2021 Fall Residents Forum meeting. The panelists share their insights about how they are navigating the early stages of their pathology careers.

This month we'll look at a lawsuit involving the implementation of the No Surprises Act, the efforts of Congress to mitigate Medicare cuts, and more.

In this CAPcast, Drs. Richard Owings, Juanita Evans, and Yasmeen Butt discuss medical errors--how to confront and move on from them, as well as how to avoid them.

In this CAPcast, Daniel Mais, MD, FCAP, discusses his recently published book, Surgical Pathology Review, which is focused on addressing these gaps.

One of the challenging aspects of transitioning from a pathologist in training to one who is new in practice is how to organize your workday. In this CAPcast, Yasmeen Butt, MD, FCAP, and Neha Varshney, MD, FCAP, discuss this topic from both a private practice and an academic practice perspective.

We sat down with four pathologists to discuss their experience and how other pathologists can work with the CAP to get involved in effective advocacy.

In this recap, we review the final Medicare fee schedule regulations, updates from Cigna, and more.

Because islet autoantibodies can also predict the development of type 1 diabetes, once safe and effective therapies are available to prevent this disease, islet autoantibody testing will become routine in medical practice, as Dr. Winter explains in this CAPcast.

In this CAPcast, Amy Daniels, the CAP's Technical Director of Accreditation Services, describes the new process for responding to deficiencies and how it impacts laboratories during the transition to the new process.

In the latest episode in our series commemorating the CAP's 75th Anniversary, we talk with past presidents Thomas Sodeman, MD, FCAP, and Bruce Williams, MD, FCAP, about discovering and nurturing the next generation of pathologist leaders.a

Molecular biomarkers can be used to confirm a diagnosis, provide prognostic information, and select targeted therapies. Pathologists need a working knowledge of these biomarkers and assays used for their evaluation to optimize patient care, explains Jennifer Yoest, MD, FCAP, a pathologist at UH Cleveland Medical Center, in this CAPcast.